首页> 外文期刊>Antiviral Research >Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
【24h】

Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection

机译:核酸聚合物:广谱抗病毒活性,抗病毒机制以及用于治疗乙型肝炎和丁型肝炎感染的优化方法

获取原文
获取原文并翻译 | 示例

摘要

Antiviral polymers are a well-studied class of broad spectrum viral attachment/entry inhibitors whose activity increases with polymer length and with increased amphipathic (hydrophobic) character. The newest members of this class of compounds are nucleic acid polymers whose activity is derived from the sequence independent properties of phosphorothioated oligonucleotides as amphipathic polymers. Although the antiviral mechanisms and broad spectrum antiviral activity of nucleic acid polymers mirror the functionality of other members of this class, they exert in addition a unique post entry activity in hepatitis B infection which inhibits the release of HBsAg from infected hepatocytes. This review provides a general overview of the antiviral polymer class with a focus on nucleic acid polymers and their development as therapeutic agents for the treatment of hepatitis B/hepatitis D. This article forms part of a symposium in Antiviral Research on "An unfinished story: from the discovery of the Australia antigen to the development of new curative therapies for hepatitis B." (C) 2016 The Author. Published by Elsevier B.V.
机译:抗病毒聚合物是广谱研究的一类广谱病毒附着/进入抑制剂,其活性随聚合物长度的增加和两亲(疏水)特性的增加而增加。这类化合物的最新成员是核酸聚合物,其活性源自硫代磷酸化寡核苷酸作为两亲性聚合物的与序列无关的特性。尽管核酸聚合物的抗病毒机制和广谱抗病毒活性反映了该类其他成员的功能,但它们在乙型肝炎感染中还具有独特的进入后活性,可抑制被感染肝细胞释放HBsAg。这篇综述概述了抗病毒聚合物的种类,重点是核酸聚合物及其作为治疗乙型肝炎/丁型肝炎的治疗剂的发展。本文构成了抗病毒研究专题研讨会的一部分,主题为“未完成的故事:从发现澳大利亚抗原到开发新的治疗乙型肝炎的疗法。” (C)2016作者。由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号